Regression of normalized left ventricular systolic function after discontinuation of treatment in patients with dilated cardiomyopathy.
Alahakoon
Prabhu T
PT
Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, 43210, USA.
Binkley
Philip F
PF
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy / Q000503:physiopathology*; D018450:Disease Progression; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D006352:Heart Ventricles; D006801:Humans; D008297:Male; D008875:Middle Aged; D013318:Stroke Volume; D013599:Systole; D013997:Time Factors; D018487:Ventricular Dysfunction, Left; D016277:Ventricular Function, Left
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics